Viewing nowTarimin Sustained-Release Tablet (Bepotastine Besilate)
Bepotastine Besylate 12.22mg
Tablet · Prescription medication
Youngjin Pharmaceutical Co., Ltd.

MFDS item code 202204557 · Approved 2022.12.21 · Insurance code 642405100
Relief of allergic rhinitis, chronic urticaria, and itchy skin (such as eczema and dermatitis)
This medication is used for the treatment of perennial allergic rhinitis, chronic urticaria, and itching associated with eczema or dermatitis.
Adults: Take 1 tablet once daily after a meal.
This medication should not be used by patients who are hypersensitive to its ingredients. It contains lactose, so patients with lactose intolerance or certain genetic metabolic disorders should not take this medication. Patients with impaired renal or liver function, as well as the elderly, should exercise caution when using this medication. Side effects may include drowsiness, headache, dizziness, dry mouth, gastrointestinal disturbances, and skin rash. Drowsiness is particularly commonly reported, so it is advisable to avoid driving or operating dangerous machinery while taking this medication. Patients receiving long-term corticosteroid treatment should gradually reduce their steroid dosage while taking this medication, and this should be done under professional supervision. Patients with reduced renal function may have elevated blood concentrations of this medication, so it is recommended to start with a low dose and adjust if symptoms appear. For patients with seasonal allergic rhinitis, it is preferable to start taking this medication before symptoms begin and to continue taking it throughout the symptom duration. If no effect is observed, it is recommended not to continue taking it for long periods. It is safe to avoid taking this medication with other antihistamines or excessive alcohol. Pregnant women or women who may become pregnant should avoid taking this medication, and if unavoidable, should consult a doctor before use. Nursing mothers are also advised to avoid breastfeeding while taking this medication. Safety in children has not been established, so it is best not to use it in pediatric patients. Elderly patients should be cautious as the drug concentration may increase due to decreased renal function. This medication can affect the results of allergy tests, so it is advisable to discontinue use before allergy testing. Store this medicine out of reach of children, and do not transfer the medication to another container.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in an airtight container to prevent exposure to air or moisture. The storage temperature should be kept between 1°C and 30°C (room temperature).
White round film-coated tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowBepotastine Besylate 12.22mg
Tablet · Prescription medication
Youngjin Pharmaceutical Co., Ltd.

Bepotastine Besylate 10mg
Tablet · Prescription medication
Hanin Pharmaceutical Co., Ltd.

Bepotastine Besylate 10mg
Tablet · Prescription medication
Daehan New Pharm Co., Ltd.

Bepotastine Besylate 10mg
Tablet · Prescription medication
Huons Co., Ltd.

Bepotastine Besylate 10mg
Tablet · Prescription medication
International Pharmaceuticals Co., Ltd.

Bepotastine Besylate 10mg
Tablet · Prescription medication
Hyundai Pharmaceutical Co., Ltd.

Bepotastine Besylate 10mg
Tablet · Prescription medication
Genupharm Co., Ltd.

Bepotastine Besylate 13mg
Tablet · Prescription medication
Huvis Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.